2022-11-15
2022-12-11
2022-11-25
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2022-11-16
2023-08-07
全球首个CRISPR-Cas9基因编辑疗法exa-cel要上市了
2023-01-28
2022-12-21
持续布局CGT,阿斯利康与Revvity达成合作,获得基因编辑技术
2023-05-19
2023-04-09
2022-11-15
2023-05-02